803PRandomized trial of androgen deprivation therapy (ADT) + enzalutamide (Arm A) versus ADT + bicalutamide (Arm B) in metastatic hormone sensitive prostate cancer (mHSPC). (23rd October 2018) - Vaishampayan, U N; Heilbrun, L; Monk, P; Sonpavde, G; Tejwani, S; Heath, E I; Fontana, J; Chinni, S